Axisresearch
List of Categories
- Aerospace & Defense
- Agriculture
- Animal Nutrition & Wellness
- Automation
- Automotive
- Chemical & Materials
- Consumer Goods and Services
- Electronics
- Energy & Mining
- Financial Services & Investment Intelligence
- Food & Beverage
- Healthcare
- Heavy Industry
- Home & Property Improvement
- Information & Communications Technology
- Investment Opportunities
- Manufacturing
- NEO
- Others
- Packaging
- Retail
- Technology & Media
- Transportation & Logistics
Sorted by Name
Publishers
Categories
Countries
CARDIOVASCULAR IMPLANTS MARKET: GLOBAL INDUSTRY TRENDS, SHARE, SIZE, GROWTH, OPPORTUNITY AND FORECAST 2019-2024
| Healthcare | Published by: IMARC GROUP | Market: |
| 135 pages | Published: 02-11-2019 |
- Healthcare
- IMARC GROUP
- 135 pages
- Published: 02-11-2019
The global cardiovascular implants market was worth US$ 19.8 Billion in 2018. Cardiovascular implants are used for patients suffering from cardiovascular conditions such as heart failure, myocardial infarction, and peripheral arterial and coronary artery diseases. Depending on their intended use, there are two broad categories of cardiovascular implants. The first type of implants remain inside the patients’ body throughout their lives to support or perform heart functions. On the other hand, temporary implants are utilized during surgeries or other medical procedures for taking over or managing heart functions. The growing prevalence of heart diseases, owing to changing dietary patterns, sedentary lifestyles and rising geriatric population, has resulted in high demand for cardiovascular implants across the globe.
Global Cardiovascular Implants Market Drivers:
Rising prevalence of cardiovascular disorders represents a key factor driving the demand of cardiovascular implants. Catalyzed by unhealthy diets and sedentary lifestyles, the prevalence of various cardiovascular disorders has increased across both developed and developing countries. Improving efficacy and safety of cardiovascular implants represents another major factor spurring the market growth. For instance, recent advancements in technology have opened opportunities for developing smart stent devices which can improve the diagnosis as well treatment of previously unmanageable conditions such as atherosclerosis and central line access failure. Apart from this, various government and non-profit organizations are also taking initiatives to improve the affordability of these devices. Other factors driving this market include ageing population, development in medical infrastructure, growing awareness levels and rising popularity of minimally invasive surgeries. Looking forward, the market value is projected to exceed US$ 27.1 Billion by 2024, expanding at a CAGR of around 5% during 2019-2024.
Market Summary:
Based on the product type, the market has been segmented into coronary stent, ICD, heart valve, implanted cardiac pacemaker, CRT device and peripheral stent.
Based on the material, the market has been segmented into metals and alloys, polymers and biological materials.
Based on the procedure type, the market has been segmented into angioplasty and open-heart surgery.
Based on the indication, the market has been segmented into arrhythmias, myocardial ischemia, acute myocardial infarction, congestive heart failure and others.
Region-wise, the market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
The competitive landscape of the market has also been examined with some of the key players being Biotronik, Abbott Laboratories, AMG International, B-Braun, Johnson & Johnson, W.L. Gore & Associates, Medtronic, Boston Scientific, Sorin, Edwards Lifesciences, Fortimedix, Neovasc Inc., On-X Life Technologies, Proxy Biomedical, Reva Medical and Shree Pacetronix Ltd.
Key Questions Answered in This Report:
- How has the global cardiovascular implants market performed so far and how will it perform in the coming years?
- What is the breakup of the global cardiovascular implants market on the basis of region?
- What is the breakup of the global cardiovascular implants market on the basis of product?
- What is the breakup of the global cardiovascular implants market on the basis of material?
- What is the breakup of the global cardiovascular implants market on the basis of procedure type?
- What is the breakup of the global cardiovascular implants market on the basis of indication?
- What are the various stages in the value chain of the global cardiovascular implants market?
- What are the key driving factors and challenges in the global cardiovascular implants market?
- What is the structure of the global cardiovascular implants market and who are the key players?
- What is the degree of competition in the global cardiovascular implants market?
| 1. Preface 2. Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3. Executive Summary 4. Introduction 4.1 Overview 4.2 Properties 4.3 Key Industry Trends 5. Global Cardiovascular Implants Market 5.1 Market Overview 5.2 Market Performance 5.3 Market Breakup by Product 5.4 Market Breakup by Material 5.5 Market Breakup by Procedure Type 5.6 Market Breakup by Indication 5.7 Market Breakup by Region 5.8 Market Forecast 6. Market Breakup by Product 6.1 Coronary Stent 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 ICD 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Heart Valve 6.3.1 Market Trends 6.3.2 Market Forecast 6.4 Implanted Cardiac Pacemaker 6.4.1 Market Trends 6.4.2 Market Forecast 6.5 CRT Device 6.5.1 Market Trends 6.5.2 Market Forecast 6.6 Peripheral Stent 6.6.1 Market Trends 6.6.2 Market Forecast 7. Market Breakup by Material 7.1 Metals and Alloys 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Polymers 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Biological Materials 7.3.1 Market Trends 7.3.2 Market Forecast 8. Market Breakup by Procedure Type 8.1 Angioplasty 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Open Heart Surgery 8.2.1 Market Trends 8.2.2 Market Forecast 9. Market Breakup by Indication 9.1 Arrhythmias 9.1.1 Market Trends 9.1.2 Market Forecast 9.2 Myocardial Ischemia 9.2.1 Market Trends 9.2.2 Market Forecast 9.3 Acute Myocardial Infarction 9.3.1 Market Trends 9.3.2 Market Forecast 9.4 Congestive Heart Failure 9.4.1 Market Trends 9.4.2 Market Forecast 9.5 Others 9.5.1 Market Trends 9.5.2 Market Forecast 10. Market Breakup by Region 10.1 North America 10.1.1 Market Trends 10.1.2 Market Forecast 10.2 Europe 10.2.1 Market Trends 10.2.2 Market Forecast 10.3 Asia Pacific 10.3.1 Market Trends 10.3.2 Market Forecast 10.4 Middle East and Africa 10.4.1 Market Trends 10.4.2 Market Forecast 10.5 Latin America 10.5.1 Market Trends 10.5.2 Market Forecast 11. Global Cardiovascular Implants Industry: SWOT Analysis 11.1 Overview 11.2 Strengths 11.3 Weaknesses 11.4 Opportunities 11.5 Threats 12 .Global Cardiovascular Implants Industry: Value Chain Analysis 13. Global Cardiovascular Implants Industry: Porters Five Forces Analysis 13.1 Overview 13.2 Bargaining Power of Buyers 13.3 Bargaining Power of Suppliers 13.4 Degree of Competition 13.5 Threat of New Entrants 13.6 Threat of Substitutes 14. Global Cardiovascular Implants Industry: Price Analysis 15. Competitive Landscape 15.1 Market Structure 15.2 Key Players 15.3 Profiles of Key Players 15.3.1 Biotronik 15.3.2 Abbott Laboratories 15.3.3 AMG International 15.3.4 B-Braun 15.3.5 Johnson & Johnson 15.3.6 W.L. Gore & Associates 15.3.7 Medtronic 15.3.8 Boston Scientific 15.3.9 Sorin 15.3.10 Edwards Lifesciences 15.3.11 Fortimedix 15.3.12 Neovasc Inc. 15.3.13 On-X Life Technologies 15.3.14 Proxy Biomedical 15.3.15 Reva Medical 15.3.16 Shree Pacetronix Ltd |
Market Breakup by Product
- Coronary Stent
- ICD
- Heart Valve
- Implanted Cardiac Pacemaker
- CRT Device
- Peripheral Stent
Market Breakup by Material
- Metals and Alloys
- Polymers
- Biological Materials
Market Breakup by Procedure Type
- Angioplasty
- Open Heart Surgery
Market Breakup by Indication
- Arrhythmias
- Myocardial Ischemia
- Acute Myocardial Infarction
- Congestive Heart Failure
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
CARDIAC BIOMARKERS MARKET: GLOBAL INDUSTRY TRENDS, SHARE, SIZE, GROWTH, OPPORTUNITY AND FORECAST 2019-2024
| Healthcare | Published by: IMARC GROUP | Market: |
| 130 pages | Published: 02-11-2019 |
- Healthcare
- IMARC GROUP
- 130 pages
- Published: 02-11-2019
The global cardiac biomarkers market was worth US$ 6.9 Billion in 2018. Cardiac markers, also known as cardiac biomarkers, are released into the bloodstream when the heart is stressed, or its muscles are damaged. These markers include different types of enzymes, hormones, and proteins, such as cardiac troponins, creatine kinase (CK), ischemia-modified albumin (IMA), and myoglobin. Measurement and testing of these markers can help in diagnosing heart conditions like cardiac ischemia and acute coronary syndrome (ACS). At present, the triage and diagnostic systems used for determining the risk of these conditions are based on electrocardiograms (ECGs) and clinical history. However, these systems are insufficient and can lead to misdiagnosis or delay in treatment. As cardiac marker testing offers higher accuracy and can identify the conditions in the early stages of presentation, they are gaining traction across the globe. These markers can also help in monitoring the prognosis of these condition with greater accuracy and providing the most effective treatment to the patients. Looking forward, the market value is projected to reach US$ 11.6 Billion by 2024, expanding at a CAGR of around 9% during 2019-2024.
Global Cardiac Biomarkers Market Drivers:
Over the past few years, there has been a rise in the number of patients suffering from ACS which has created a demand for cardiac marker testing at a global level. Other than this, rising awareness among patients and healthcare providers about the importance of early diagnosis of various CVDs is driving the demand for these markers. In addition, there are numerous private and public organizations which are investing in R&D activities to develop advanced technologies in the field of cardiac biomarkers. For instance, blood tests for high-sensitivity cardiac troponin I have been demonstrated to identify patients who are at a higher risk of a second heart attack. Moreover, high accuracy and rapid results offered by biomarker testing, coupled with the availability of affordable cardiac point-of-care testing, are some of the other factors which are contributing to the growth of the market.
Market Summary:
Based on the type, the market has been segmented into troponins (T and I), myocardial muscle creatine kinase (CK-MB), myoglobin, brain natriuretic peptide (BNPs) or NT-proBNP, ischemia modified albumin (IMA) and others.
Based on the location of testing, the market has been segmented into laboratory testing and point of care testing. Laboratory testing currently accounts for a larger share.
Based on the application, the market has been segmented into myocardial infarction, congestive heart failure, acute coronary syndrome, atherosclerosis and others. Myocardial infarction currently accounts for the highest share.
Region-wise, the market has been segmented into North America, Asia Pacific, Europe, Middle East and Africa, and Latin America. Amongst these, North America is the biggest market, accounting for the majority of the global share.
The competitive landscape of the market has also been examined with some of the key players being Abbott Laboratories, Alere Inc., Beckman Coulter, Becton, Dickinson And Co., Biomerieux, Bio-Rad Laboratories, Randox Laboratories, Roche Diagnostics Corporation, Siemens Healthcare and Thermo Fisher Scientific.
Key Questions Answered in This Report:
- How has the global cardiac biomarkers market performed so far and how will it perform in the coming years?
- What are the key regional markets in the global cardiac biomarkers industry?
- What is the breakup of the global cardiac biomarkers market on the basis of type?
- What is the breakup of the global cardiac biomarkers market on the basis of location of testing?
- What is the breakup of the global cardiac biomarkers market on the basis of application?
- What are the various stages in the value chain of the global cardiac biomarkers market?
- What are the key driving factors and challenges in the global cardiac biomarkers market?
- What is the structure of the global cardiac biomarkers market and who are the key players?
- What is the degree of competition in the global cardiac biomarkers market?
| 1. Preface 2. Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3. Executive Summary 4. Introduction 4.1 Overview 4.2 Key Industry Trends 5. Global Cardiac Biomarkers Market 5.1 Market Overview 5.2 Market Performance 5.3 Market Breakup by Type 5.4 Market Breakup by Location of Testing 5.5 Market Breakup by Application 5.6 Market Breakup by Region 5.7 Market Forecast 6. Market Breakup by Type 6.1 Troponins (T and I) 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Myocardial Muscle Creatine Kinase (CK-MB) 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Myoglobin 6.3.1 Market Trends 6.3.2 Market Forecast 6.4 Brain Natriuretic Peptide (BNPs) or NT-proBNP 6.4.1 Market Trends 6.4.2 Market Forecast 6.5 Ischemia Modified Albumin (IMA) 6.5.1 Market Trends 6.5.2 Market Forecast 6.6 Others 6.6.1 Market Trends 6.6.2 Market Forecast 7. Market Breakup by Location of Testing 7.1 Laboratory Testing 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Point of Care Testing 7.2.1 Market Trends 7.2.2 Market Forecast 8. Market Breakup by Application 8.1 Myocardial Infarction 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Congestive Heart Failure 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Acute Coronary Syndrome 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Atherosclerosis 8.4.1 Market Trends 8.4.2 Market Forecast 8.5 Others 8.5.1 Market Trends 8.5.2 Market Forecast 9. Market Breakup by Region 9.1 North America 9.1.1 Market Trends 9.1.2 Market Forecast 9.2 Asia Pacific 9.2.1 Market Trends 9.2.2 Market Forecast 9.3 Europe 9.3.1 Market Trends 9.3.2 Market Forecast 9.4 Middle East and Africa 9.4.1 Market Trends 9.4.2 Market Forecast 9.5 Latin America 9.5.1 Market Trends 9.5.2 Market Forecast 10. Global Cardiac Biomarkers Industry: SWOT Analysis 10.1 Overview 10.2 Strengths 10.3 Weaknesses 10.4 Opportunities 10.5 Threats 11. Global Cardiac Biomarkers Industry: Value Chain Analysis 12. Global Cardiac Biomarkers Industry: Porters Five Forces Analysis 12.1 Overview 12.2 Bargaining Power of Buyers 12.3 Bargaining Power of Suppliers 12.4 Degree of Competition 12.5 Threat of New Entrants 12.6 Threat of Substitutes 13. Global Cardiac Biomarkers Industry: Price Analysis 14. Competitive Landscape 14.1 Market Structure 14.2 Key Players 14.3 Profiles of Key Players 14.3.1 Abbott Laboratories 14.3.2 Alere Inc. 14.3.3 Beckman Coulter 14.3.4 Becton, Dickinson And Co. 14.3.5 Biomerieux 14.3.6 Bio-Rad Laboratories 14.3.7 Randox Laboratories 14.3.8 Roche Diagnostics Corporation 14.3.9 Siemens Healthcare 14.3.10 Thermo Fisher Scientific |
Market Breakup by Type
- Troponins (T and I)
- Myocardial Muscle Creatine Kinase (CK-MB)
- Myoglobin
- Brain Natriuretic Peptide (BNPs) or NT-proBNP
- Ischemia Modified Albumin (IMA)
- Others
Market Breakup by Location of Testing
- Laboratory Testing
- Point of Care Testing
Market Breakup by Application
- Myocardial Infarction
- Congestive Heart Failure
- Acute Coronary Syndrome
- Atherosclerosis
- Others
Market Breakup by Region
- North America
- Asia Pacific
- Europe
- Middle East and Africa
- Latin America
ORTHOPEDIC BRACES AND SUPPORTS MARKET: GLOBAL INDUSTRY TRENDS, SHARE, SIZE, GROWTH, OPPORTUNITY AND FORECAST 2019-2024
| Healthcare | Published by: IMARC GROUP | Market: |
| 122 pages | Published: 02-11-2019 |
- Healthcare
- IMARC GROUP
- 122 pages
- Published: 02-11-2019
The global orthopedic braces and supports market was worth US$ 3.8 Billion in 2018. Braces and supports are orthopedic equipment which are used externally for holding, aligning, correcting and supporting certain parts of the body while healing from an injury. They are manufactured using specialized materials with intelligent designs that offer intense targeted support to the knee, spine, foot, ankle, upper elbow, shoulder, hip and other body parts. Braces and supports also aid in safeguarding joints after surgeries and offer a sense of mobility to the patients suffering from musculoskeletal problems. Looking forward, the market value is projected to reach US$ 4.9 Billion by 2024, growing at a CAGR of 4.5% during 2019-2024.
Global Orthopedic Braces and Supports Market Drivers:
In comparison with invasive treatments, braces and supports are less painful, assist in quick recovery and reduce the incidences of post-surgical complications. On account of these factors, orthopedic braces and supports are preferred by patients worldwide.
Nowadays, consumers spend a significant part of their day in front of PCs, TVs and smart devices which result in the development of minor and major musculoskeletal deformities and dysfunctions. As a result, the demand for braces and supports is proliferating at a healthy rate.
The geriatric population is at a relatively higher risk of developing spondylitis, osteoarthritis, degenerative disc disease, and other mobility issues. Therefore, the growing elderly population is also contributing to the sales of braces and supports across the globe.
Manufacturers are developing pliable braces with a simplified user-interface, considering the requirements of consumers. They are also incorporating Velcro instead of laces to enable easy application and pulley systems in lumbar supports to allow easy customization.
Technological advancements have led to significant improvements in modeling and material technology and increased flexibility, contouring, and utilization of low-weight materials. Innovations have also led to the incorporation of advanced data sensors and synchronization systems.
Market Summary:
Based on the product, the market has been segmented into lower extremity braces and supports; spinal braces and supports; and upper extremity braces and supports.
Based on the type, the market has been segmented into soft and elastic braces and supports; hinged braces and supports; and hard and rigid braces and supports. Soft and elastic braces and supports currently have the highest share.
Based on the application, the market has been segmented into ligament injury, preventive care, post-operative rehabilitation, osteoarthritis and others. Ligament injury currently accounts for the highest share.
Based on the end-user, the market has been segmented into orthopedic clinics; hospitals and surgical centers; over-the-counter (OTC) platforms; and others. Orthopedic clinics currently account for the highest share.
Region-wise, the market has been segmented into North America, Asia Pacific, Europe, Middle East and Africa, and Latin America. Amongst these, North America is the biggest market, accounting for the majority of the global share.
The competitive landscape of the market has also been examined with some of the key players being Breg, Inc., Össur Hf, Bauerfeind AG, BSN Medical, DJO Finance LLC, 3M Company, Otto Bock Healthcare, Deroyal Industries, Inc., Medi GmbH & Co. KG, Thuasne Group, Alcare Co., Ltd, Zimmer Biomet Holdings, Inc., Trulife, Remington Products Company and Bird & Cronin.
Key Questions Answered in This Report:
- How has the global orthopedic braces and supports market performed so far and how will it perform in the coming years?
- What are the key regional markets in the global orthopedic braces and supports industry?
- What is the breakup of the global orthopedic braces and supports market on the basis of product?
- What is the breakup of the global orthopedic braces and supports market on the basis of type?
- What is the breakup of the global orthopedic braces and supports market on the basis of application?
- What is the breakup of the global orthopedic braces and supports market on the basis of end-user?
- What are the various stages in the value chain of the global orthopedic braces and supports market?
- What are the key driving factors and challenges in the global orthopedic braces and supports market?
- What is the structure of the global orthopedic braces and supports market and who are the key players?
- What is the degree of competition in the global orthopedic braces and supports market?
| 1 Preface 2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Orthopedic Braces and Supports Market 5.1 Market Overview 5.2 Market Performance 5.3 Market Breakup by Product 5.4 Market Breakup by Type 5.5 Market Breakup by Application 5.6 Market Breakup by End-User 5.7 Market Breakup by Region 5.8 Market Forecast 6 Market Breakup by Product 6.1 Lower Extremity Braces and Supports 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Spinal Braces and Supports 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Upper Extremity Braces and Supports 6.3.1 Market Trends 6.3.2 Market Forecast 7 Market Breakup by Type 7.1 Soft and Elastic Braces and Supports 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Hinged Braces and Supports 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Hard and Rigid Braces and Supports 7.3.1 Market Trends 7.3.2 Market Forecast 8 Market Breakup by Application 8.1 Ligament Injury 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Preventive Care 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Post-Operative Rehabilitaion 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Osteoarthritis 8.4.1 Market Trends 8.4.2 Market Forecast 8.5 Others 8.5.1 Market Trends 8.5.2 Market Forecast 9 Market Breakup by End-User 9.1 Orthopedic Clinics 9.1.1 Market Trends 9.1.2 Market Forecast 9.2 Hospitals and Surgical Centers 9.2.1 Market Trends 9.2.2 Market Forecast 9.3 Over-the-Counter (OTC) Platforms 9.3.1 Market Trends 9.3.2 Market Forecast 9.4 Others 9.4.1 Market Trends 9.4.2 Market Forecast 10 Market Breakup by Region 10.1 North America 10.1.1 Market Trends 10.1.2 Market Forecast 10.2 Asia Pacific 10.2.1 Market Trends 10.2.2 Market Forecast 10.3 Europe 10.3.1 Market Trends 10.3.2 Market Forecast 10.4 Middle East and Africa 10.4.1 Market Trends 10.4.2 Market Forecast 10.5 Latin America 10.5.1 Market Trends 10.5.2 Market Forecast 11 Global Orthopedic Braces and Supports Industry: SWOT Analysis 11.1 Overview 11.2 Strengths 11.3 Weaknesses 11.4 Opportunities 11.5 Threats 12 Global Orthopedic Braces and Supports Industry: Value Chain Analysis 13 Global Orthopedic Braces and Supports Industry: Porters Five Forces Analysis 13.1 Overview 13.2 Bargaining Power of Buyers 13.3 Bargaining Power of Suppliers 13.4 Degree of Competition 13.5 Threat of New Entrants 13.6 Threat of Substitutes 14 Global Orthopedic Braces and Supports Industry: Price Analysis 15 Competitive Landscape 15.1 Market Structure 15.2 Key Players 15.3 Profiles of Key Players 15.3.1 Breg, Inc. 15.3.2 Össur Hf 15.3.3 Bauerfeind AG 15.3.4 BSN Medical 15.3.5 DJO Finance LLC 15.3.6 3M Company 15.3.7 Otto Bock Healthcare 15.3.8 Deroyal Industries, Inc. 15.3.9 Medi GmbH & Co. KG 15.3.10 Thuasne Group 15.3.11 Alcare Co., Ltd 15.3.12 Zimmer Biomet Holdings, Inc. 15.3.13 Trulife 15.3.14 Remington Products Company 15.3.15 Bird & Cronin |
Market Breakup by Product
- Lower Extremity Braces and Supports
- Spinal Braces and Supports
- Upper Extremity Braces and Supports
Market Breakup by Type
- Soft and Elastic Braces and Supports
- Hinged Braces and Supports
- Hard and Rigid Braces and Supports
Market Breakup by Application
- Ligament Injury
- Preventive Care
- Post-Operative Rehabilitaion
- Osteoarthritis
- Others
Market Breakup by End-User
- Orthopedic Clinics
- Hospitals and Surgical Centers
- Over-the-Counter (OTC) Platforms
- Others
Market Breakup by Region
- North America
- Asia Pacific
- Europe
- Middle East and Africa
- Latin America
DRY EYE SYNDROME MARKET: GLOBAL INDUSTRY TRENDS, SHARE, SIZE, GROWTH, OPPORTUNITY AND FORECAST 2019-2024
| Healthcare | Published by: IMARC GROUP | Market: |
| 118 pages | Published: 02-11-2019 |
- Healthcare
- IMARC GROUP
- 118 pages
- Published: 02-11-2019
The global dry eye syndrome market was worth US$ 3.5 Billion in 2018. Dry eye syndrome, medically known as keratoconjunctivitis sicca (KCS), is a term that defines the lack of lubrication or moisture on the surface of the infected person’s eyes. It is a commonly occurring disease which can affect almost anyone. Various symptoms of dry eye include aching and burning sensations, sore eyes, red eyes, fatigued eyes, itchy eyes, photophobia, etc. Apart from this, watery eyes can also be a symptom as the dry surface of the eyes over-stimulate the production of watery component of tears in order to reduce the dryness. There are several factors that can cause dry eye syndrome such as excessive computer use, allergies, aging, menopause, smoking, LASIK eye surgery, hormone replacement therapy, etc.
Various diseases, such as diabetes, thyroid disorders, Sjogren’s syndrome, lupus, scleroderma, rheumatoid arthritis, etc., are also contributing to the prevalence of dry eyes among people. As per statistics, around 425-430 Million individuals across the globe get affected by diabetes. It causes constant changes in the composition of patient’s blood which adversely affects the tear glands resulting in a rising prevalence of dry eye. Another key factor which is contributing to the growth of the market is the rising geriatric population. As per estimates, around 9% of the global population is above 65 years of age, and by 2050 this segment is expected to account for around 17% of the global population. With the prevalence of dry eyes being fairly high among the elderly, we expect the market for dry eye syndrome to exhibit a strong growth. Other factors augmenting the growth of this market include increasing awareness levels, rising diagnostic rates, better treatment options, etc. Looking forward, the market value is projected to reach US$ 5.1 Billion by 2024, exhibiting a CAGR of 6.5% during 2019-2024.
Market Summary:
Based on the disease type, the market has been segmented into evaporative dry eye syndrome and aqueous dry eye syndrome.
Based on the drug type, the market has been segmented into lubricant eye drops, anti-inflammatory drugs and autologous serum eye drops.
Based on the product type, the market has been segmented into liquid drops, gel, liquid wipes, eye ointment and others.
Based on the distribution channels, the market has been segmented into retail pharmacies, hospital pharmacies and online pharmacies.
Region-wise, the market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
The competitive landscape of the market has also been examined with some of the key players being Novartis AG, Allergan plc., Otsuka Holdings Co., Ltd., Santen Pharmaceutical Co., Ltd., Nicox S.A., Auven Therapeutics, Akorn, Inc., Bausch + Lomb, Alimera Science and GlaxoSmithKline plc.
This report provides a deep insight into the global dry eye syndrome market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the dry eye syndrome market in any manner.
Key Questions Answered in This Report:
- How has the global dry eye syndrome market performed so far and how will it perform in the coming years?
- What is the breakup of the global dry eye syndrome market on the basis of region?
- What is the breakup of the global dry eye syndrome market on the basis of disease type?
- What is the breakup of the global dry eye syndrome market on the basis of drug type?
- What is the breakup of the global dry eye syndrome market on the basis of product type?
- What is the breakup of the global dry eye syndrome market on the basis of distribution channel?
- What are the various stages in the value chain of the global dry eye syndrome market?
- What are the key driving factors and challenges in the global dry eye syndrome market?
- What is the structure of the global dry eye syndrome market and who are the key players?
- What is the degree of competition in the global dry eye syndrome market?
| 1 Preface 2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Properties 4.3 Key Industry Trends 5 Global Dry Eye Syndrome Market 5.1 Market Overview 5.2 Market Performance 5.3 Market Breakup by Disease Type 5.4 Market Breakup by Drug Type 5.5 Market Breakup by Product 5.6 Market Breakup by Distribution Channels 5.7 Market Breakup by Region 5.8 Market Forecast 6 Market Breakup by Disease Type 6.1 Evaporative Dry Eye Syndrome 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Aqueous Dry Eye Syndrome 6.2.1 Market Trends 6.2.2 Market Forecast 7 Market Breakup by Drug Type 7.1 Lubricant Eye Drops 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Anti-inflammatory Drugs 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Autologous Serum Eye Drops 7.3.1 Market Trends 7.3.2 Market Forecast 8 Market Breakup by Product 8.1 Liquid Drops 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Gel 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Liquid Wipes 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Eye Ointment 8.4.1 Market Trends 8.4.2 Market Forecast 8.5 Others 8.5.1 Market Trends 8.5.2 Market Forecast 9 Market Breakup by Distribution Channel 9.1 Retail Pharmacies 9.1.1 Market Trends 9.1.2 Market Forecast 9.2 Hospital Pharmacies 9.2.1 Market Trends 9.2.2 Market Forecast 9.3 Online Pharmacies 9.3.1 Market Trends 9.3.2 Market Forecast 10 Market Breakup by Region 10.1 North America 10.1.1 Market Trends 10.1.2 Market Forecast 10.2 Europe 10.2.1 Market Trends 10.2.2 Market Forecast 10.3 Asia Pacific 10.3.1 Market Trends 10.3.2 Market Forecast 10.4 Middle East and Africa 10.4.1 Market Trends 10.4.2 Market Forecast 10.5 Latin America 10.5.1 Market Trends 10.5.2 Market Forecast 11 Global Dry Eye Syndrome Industry: SWOT Analysis 11.1 Overview 11.2 Strengths 11.3 Weaknesses 11.4 Opportunities 11.5 Threats 12 Global Dry Eye Syndrome Industry: Value Chain Analysis 13 Global Dry Eye Syndrome Industry: Porters Five Forces Analysis 13.1 Overview 13.2 Bargaining Power of Buyers 13.3 Bargaining Power of Suppliers 13.4 Degree of Competition 13.5 Threat of New Entrants 13.6 Threat of Substitutes 14 Global Dry Eye Syndrome Industry: Price Analysis 14.1 Price Indicators 14.2 Price Structure 14.3 Margin Analysis 15 Manufacturing Process 15.1 Product Overview 15.2 Raw Material Requirements 15.3 Manufacturing Process 15.4 Key Success and Risk Factors 16 Competitive Landscape 16.1 Market Structure 16.2 Key Players 16.3 Profiles of Key Players 16.3.1 Novartis AG 16.3.2 Allergan plc. 16.3.3 Otsuka Holdings Co., Ltd. 16.3.4 Santen Pharmaceutical Co., Ltd. 16.3.5 Nicox S.A. 16.3.6 Auven Therapeutics 16.3.7 Akorn, Inc. 16.3.8 Bausch + Lomb 16.3.9 Alimera Science 16.3.10 GlaxoSmithKline plc |
Market Breakup by Disease Type
- Evaporative Dry Eye Syndrome
- Aqueous Dry Eye Syndrome
Market Breakup by Drug Type
- Lubricant Eye Drops
- Anti-inflammatory Drugs
- Autologous Serum Eye Drops
Market Breakup by Product
- Liquid Drops
- Gel
- Liquid Wipes
- Eye Ointment
- Others
Market Breakup by Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: GLOBAL INDUSTRY TRENDS, SHARE, SIZE, GROWTH, OPPORTUNITY AND FORECAST 2019-2024
| Healthcare | Published by: IMARC GROUP | Market: |
| 151 pages | Published: 02-11-2019 |
- Healthcare
- IMARC GROUP
- 151 pages
- Published: 02-11-2019
The global active pharmaceutical ingredients market was worth US$ 176.3 Billion in 2018. Active pharmaceutical ingredient (API), is the term that is used to refer to the biologically active component of a drug (e.g. tablet, capsule). A drug is usually composed of several components. The API represents the primary ingredient. Other ingredients are commonly known as “excipients. Sometimes a drug can contain several APIs and its effect on a patient depends on the dosage prescribed and can vary from person to person. In combination therapies, two or more than two active ingredients are used to treat different symptoms in different ways. Stringent quality control is a mandate when it comes to the manufacturing of drugs as the API represents the main component considered while making the prescription.
Pharmaceutical manufacturing occurs in two general steps. In the first step, manufacturers convert raw materials into APIs. The second step involves creating the final formulation by mixing APIs and excipients into tablets, capsules, solutions, etc. and finally packaging the drug for the end users. Manufacturers either sell APIs in the open market (also known as the merchant market) or use them as inputs to make their final formulations. The global API market is extremely competitive with a number of large and small manufacturers. Firms that engage in API manufacturing generally specialize and target their manufacturing based on a combination of the firms in-house skills and market opportunities. Catalyzed by lower costs, API manufacturing has gradually been shifting from the historical leaders in Western countries to manufacturers based in India and China.
The global demand of APIs is currently exhibiting strong growth. One of the major drivers of this market is the rising number of blockbuster patent expiries creating a significant opportunity for generic APIs. Moreover, there has been a strong demand for APIs for biologicals. The global market for biologicals is currently exhibiting strong growth catalyzed by their high potency and ability to treat diseases beyond the scope of small molecule drugs. This is creating a strong demand for APIs for branded biological drugs and their biosimilar versions. Other factors catalyzing the global demand of APIs include ageing population, rising expenditures on healthcare, increasing prevalence of lifestyle diseases, etc. Looking forward, the market value is projected to reach US$ 247.2 Billion by 2024, exhibiting a CAGR of 5.8% during 2019-2024.
Market Summary:
Based on the drug type, the market has been segmented as innovative active pharmaceutical ingredients and generic active pharmaceutical ingredients.
Based on the type of manufacturer, the market has been segmented as captive manufacturers and merchant API manufacturers.
Based on the type of synthesis, the market has been segmented as synthetic active pharmaceutical ingredients and biotech active pharmaceutical ingredients.
Based on the therapeutic application, the market has been segmented as oncology, cardiovascular disease, diabetes, central nervous system and neurological disorders, endocrinology and others.
Region-wise, the market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
The competitive landscape of the market has also been examined with some of the key players being Pfizer, Inc., Novartis International AG, Sanofi, Boehringer Ingelheim, Bristol-Myers Squibb, Teva Pharmaceutical Industries Ltd., ELI Lilly and Company, GlaxoSmithKline, Merck & Co., Inc. and Abbvie Inc.
Key Questions Answered in This Report:
- How has the global active pharmaceutical ingredients market performed so far and how will it perform in the coming years?
- What are the key regional markets in the global active pharmaceutical ingredients industry?
- What is the breakup of the global active pharmaceutical ingredients market on the basis of drug type?
- What is the breakup of the global active pharmaceutical ingredients market on the basis of type of manufacturer?
- What is the breakup of the global active pharmaceutical ingredients market on the basis of synthesis?
- What is the breakup of the global active pharmaceutical ingredients market on the basis of therapeutic application?
- What are the various stages in the value chain of the global active pharmaceutical ingredients market?
- What are the key driving factors and challenges in the global active pharmaceutical ingredients market?
- What is the structure of the global active pharmaceutical ingredients market and who are the key players?
- What is the degree of competition in the global active pharmaceutical ingredients market?
- How are active pharmaceutical ingredients manufactured?
| 1 Preface 2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Active Pharmaceutical Ingredients Market 5.1 Market Overview 5.2 Market Performance 5.3 Market Breakup by Drug Type 5.4 Market Breakup by Type of Manufacturer 5.5 Market Breakup by Type of Synthesis 5.6 Market Breakup by Therapeutic Application 5.7 Market Breakup by Region 5.8 Market Forecast 5.9 SWOT Analysis 5.9.1 Overview 5.9.2 Strengths 5.9.3 Weaknesses 5.9.4 Opportunities 5.9.5 Threats 5.10 Value Chain Analysis 5.11 Porters Five Forces Analysis 5.11.1 Overview 5.11.2 Bargaining Power of Buyers 5.11.3 Bargaining Power of Suppliers 5.11.4 Degree of Competition 5.11.5 Threat of New Entrants 5.11.6 Threat of Substitutes 5.12 Price Analysis 5.12.1 Price Indicators 5.12.2 Price Structure 5.12.3 Margin Analysis 6 Market Breakup by Drug Type 6.1 Innovative Active Pharmaceutical Ingredients 6.2 Generic Active Pharmaceutical Ingredients 7 Market Breakup by Type of Manufacturer 7.1 Captive Manufacturers 7.2 Merchant API Manufacturers 7.2.1 Innovative Merchant API Manufacturers 7.2.2 Generic Merchant API Manufacturers 8 Market Breakup by Type of Synthesis 8.1 Synthetic Active Pharmaceutical Ingredients 8.1.1 Market Breakup by Type 8.1.1.1 Innovative Synthetic APIs 8.1.1.2 Generic Synthetic APIs 8.2 Biotech Active Pharmaceutical Ingredients 8.2.1 Market Breakup by Type 8.2.1.1 Innovative Biotech APIs 8.2.1.2 Biosimilars 8.2.2 Market Breakup By Product 8.2.2.1 Monoclonal Antibodies 8.2.2.2 Vaccines 8.2.2.3 Cytokines 8.2.2.4 Fusion Proteins 8.2.2.5 Therapeutic Enzymes 8.2.2.6 Blood Factors 8.2.3 Market Breakup By Expression System 8.2.3.1 Mammalian Expression Systems 8.2.3.2 Microbial Expression Systems 8.2.3.3 Yeast Expression Systems 8.2.3.4 Plant Expression Systems 8.2.3.5 Insect Expression Systems 9 Market Breakup by Therapeutic Application 9.1 Oncology 9.2 Cardiovascular Disease 9.3 Diabetes 9.4 Central Nervous System and Neurological Disorders 9.5 Endocrinology 9.6 Others 10 Market Breakup by Region 10.1 North America 10.2 Europe 10.3 Asia Pacific 10.4 Middle East and Africa 10.5 Latin America 11 Manufacturing Process 11.1 Product Overview 11.2 Raw Material Requirements 11.3 Manufacturing Process 11.4 Key Success and Risk Factors 12 Competitive Landscape 12.1 Market Structure 12.2 Key Players 12.3 Profiles of Key Players 12.3.1 Pfizer, Inc. 12.3.2 Novartis International AG 12.3.3 Sanofi 12.3.4 Boehringer Ingelheim 12.3.5 Bristol-Myers Squibb 12.3.6 Teva Pharmaceutical Industries Ltd. 12.3.7 ELI Lilly and Company 12.3.8 GlaxoSmithKline 12.3.9 Merck & Co., Inc. 12.3.10 Abbvie Inc. |
Market Breakup by Drug Type
Innovative Active Pharmaceutical Ingredients
Generic Active Pharmaceutical Ingredients
Market Breakup by Type of Manufacturer
Captive Manufacturers
Merchant API Manufacturers
Innovative Merchant API Manufacturers
Generic Merchant API Manufacturers
Market Breakup by Type of Synthesis
Synthetic Active Pharmaceutical Ingredients
Market Breakup by Type
Innovative Synthetic APIs
Generic Synthetic APIs
Biotech Active Pharmaceutical Ingredients
Market Breakup by Type
Innovative Biotech APIs
Biosimilars
Market Breakup By Product
Monoclonal Antibodies
Vaccines
Cytokines
Fusion Proteins
Therapeutic Enzymes
Blood Factors
Market Breakup By Expression System
Mammalian Expression Systems
Microbial Expression Systems
Yeast Expression Systems
Plant Expression Systems
Insect Expression Systems
Market Breakup by Therapeutic Application
Oncology
Cardiovascular Disease
Diabetes
Central Nervous System and Neurological Disorders
Endocrinology
Others
Market Breakup by Region
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
SAUDI ARABIA IN-VITRO DIAGNOSTICS (IVD) MARKET: INDUSTRY TRENDS, SHARE, SIZE, GROWTH, OPPORTUNITY AND FORECAST 2019-2024
| Healthcare | Published by: IMARC GROUP | Market: |
| 85 pages | Published: 02-11-2019 |
- Healthcare
- IMARC GROUP
- 85 pages
- Published: 02-11-2019
The Saudi Arabia in-vitro diagnostics (IVD) market was worth US$ 650 Million in 2018. Saudi Arabia currently represents the largest market for in-vitro diagnostics in the GCC region. In-vitro diagnostics, plays a significant role in in the Saudi Arabia healthcare system by providing accurate diagnosis and prognosis, which enables improved monitoring and treatment. Diagnostics represent only a small share of the total healthcare spending but are critical in medical decision making and reducing the burden of diseases and healthcare expenditures.
There has been a steady growth in the adoption of in-vitro diagnostics in Saudi Arabia. Increasing incidence rates of various infectious and chronic diseases represent some of the key drivers of the in-vitro diagnostics market in Saudi Arabia. The country’s population is currently around 33 Million and is growing annually at around 2%. According to Saudi Arabia’s General Authority of Statistics, elderly constituted 4.2% of the total Saudi population and are expected to increase further in the coming years. With an increasing elderly population, we expect the prevalence of a number of chronic diseases to increase significantly in the next few years. Moreover, catalyzed by rising physical inactivity and consumption of unhealthy diets, the prevalence of a number of lifestyle diseases have been increasing in the country. Saudi Arabia has one of the highest rates of obesity in the world. It is estimated that around 36% of the total population are obese. Additionally, the prevalence of hypertension was around 29% among males and around 24% among females. Saudi Arabia also has one of the highest prevalence of diabetes with around 19% of the adult population suffering from diabetes in the country. Some of the other factors catalyzing the growth of in-vitro diagnostics in Saudi Arabia include rising healthcare expenditures, improving healthcare infrastructure, initiatives by the government, rising awareness levels, etc. Looking forward, the market is further projected to reach a value of US$ 1,020 Million by 2024, growing at a CAGR of around 8% during 2019-2024.
Report Summary
Breakup by Application:
On the basis of application, the market has been segmented into infectious diseases, diabetes, blood test, nephrology, cardiology, oncology, autoimmune diseases and others.
Breakup by End-User:
Based on end-user, the report finds that hospital-based centers currently represent the leading end-user of in-vitro diagnostics in Saudi Arabia. Hospital-based centers are followed by diagnostic chains, standalone centers and others (patient self-testing, academic institutes, etc.)
Competitive Landscape:
The report also provides the competitive landscape and the profiles of key players operating in this market.
This report provides a deep insight into the Saudi Arabia in-vitro diagnostics (IVD) devices market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Saudi Arabia in-vitro diagnostics (IVD) market in any manner.
Key Questions Answered in This Report:
- How has the Saudi Arabia in-vitro diagnostics (IVD) market performed so far and how will it perform in the coming years?
- What are the key application segments in the Saudi Arabia in-vitro diagnostics (IVD) market?
- What are the major end-users in the Saudi Arabia in-vitro diagnostics (IVD) market?
- What are the various stages in the value chain of the Saudi Arabia in-vitro diagnostics (IVD) market?
- What are the key driving factors and challenges in the Saudi Arabia in-vitro diagnostics (IVD) market?
- What is the degree of competition in the Saudi Arabia in-vitro diagnostics (IVD) market?
| 1 Preface 2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Saudi Arabia In-Vitro Diagnostics Market 5.1 Market Overview 5.2 Market Performance 5.3 Market Breakup by End-User 5.4 Market Breakup by Application 5.5 Market Forecast 5.6 SWOT Analysis 5.6.1 Overview 5.6.2 Strengths 5.6.3 Weaknesses 5.6.4 Opportunities 5.6.5 Threats 5.7 Value Chain Analysis 5.8 Porters Five Forces Analysis 5.8.1 Overview 5.8.2 Bargaining Power of Buyers 5.8.3 Bargaining Power of Suppliers 5.8.4 Degree of Competition 5.8.5 Threat of New Entrants 5.8.6 Threat of Substitutes 6 Market Breakup by End-User 6.1 Hospital-Based Centres 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Diagnostics Chains 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Standalone Centres 6.3.1 Market Trends 6.3.2 Market Forecast 6.4 Others 6.4.1 Market Trends 6.4.2 Market Forecast 7 Market Breakup by Application 7.1 Infectious Diseases 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Diabetes 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Blood Test 7.3.1 Market Trends 7.3.2 Market Forecast 7.4 Nephrology 7.4.1 Market Trends 7.4.2 Market Forecast 7.5 Cardiology 7.5.1 Market Trends 7.5.2 Market Forecast 7.6 Oncology 7.6.1 Market Trends 7.6.2 Market Forecast 7.7 Autoimmune Diseases 7.7.1 Market Trends 7.7.2 Market Forecast 7.8 Others 7.8.1 Market Trends 7.8.2 Market Forecast 8 Competitive Landscape |
Market Breakup by End-User
- Hospital-Based Centres
- Diagnostics Chains
- Standalone Centres
- Others
Market Breakup by Application
- Infectious Diseases
- Diabetes
- Blood Test
- Nephrology
- Cardiology
- Oncology
- Autoimmune Diseases
- Others